Biogen, Inc. (United States)

Biogen is a pioneering biotechnology company focused on neuroscience therapeutics. Based in Cambridge, Massachusetts, Biogen develops treatments for multiple sclerosis (MS), Alzheimer’s disease, spinal muscular atrophy (SMA), and other neurological conditions. Key products include Tecfidera, Tysabri, and Vumerity for MS, Spinraza for SMA, and Leqembi (lecanemab) for early Alzheimer’s disease. Biogen’s commitment to neurological research advances understanding and treatment of devastating brain diseases.